| Merck KGaA buys Millipore
€5.3 billion deal creates bioresearch giant | |
| Evonik buys two more
Amberkat catalysts and MET join the fold | |
| EuroBioRef project to build biorefinery of the future
Many leading speciality chemicals firms take part 08 March 2010 | |
| PPD opens Irish facility
€14 million expansion in Athlone | |
| Wacker Fine Chemicals becomes Biosolutions
Name change confirms growing bio focus | |
| Aurelius has acquired Isochem from SNPE
Protests continue from unions at state-owned firm | |
| AMRI acquires Excelsyn in $19 million deal
Buy gives firm new presence in European manufacturing | |
| Codexis to work with Dishman and Ampac Fine Chemicals
Biocatalysis firm in double alliance | |
| Albemarle partners with PharmaCore
Company seeking substantial acquisitions in 2010 | |
| Proveblue proven by Novasep
Fast evaluation to follow successful scale-up | |
| DyStar operations set to restart
Kiri lays out details of rescue | |
| Three RD&T centres for Solvay in Asia
India, Korea and China to see new centres by 2012 | |
| Solvias in API manufacturing deal
Swiss firm to make lead product for Vitae | |
| Purolite and TransBiodiesel to co-operate
Significant advantages claimed for new technology | |
| BASF in spray drying deal
APIs to be tested at GEA Niro | |
| Pfizer-Peakdale: A new model for pharma R&D?
Laboratory to be set up at Sandwich site | |
| SKion close to Altana takeover
Squeeze-out looms after Klatten gets 95% | |
| BASF will continue high R&D spend
Extended CaRLa highlighted for academic collaboration | |
| Michigan to get new Powerhouse?
Dow identified main site as preferred option | |
| Siegfried Group to change to ‘functional organisation’
Two board members to have new roles | |
| BFR facility emissions continue to fall, says industry
VECAP programme enters fifth year | |
| Dorf Ketal gets DuPont’s speciality catalysts
Another buy helps Indian firm grow again | |
| Nalco forms African JV
“Strong growth opportunities” in southern Africa | |
| Dow Corning opens Polish office
Warsaw to form part of wider network | |
| AMRI gets SafeBridge certification
Numbers reach double figures after run of approvals | |
| Worth its salts
Merck KGaA begins new plant at Darmstadt | |
| DSM to close another site
Asian competition doomed DSI's Chemelot operation | |
| Columbus keeps on going
Kemira site retooled to serve oil and gas | |
| Lonza to close three sites
| |
| Almac founder McClay dies at 80
Tributes to Northern Ireland’s most successful businessman | |
| DSM Venturing invests in green chemistry and biogas firms
Segestis and Bioprocess Control bring total to 16 | |
| Charles River suspends Shrewsbury site
Operations to resume when market recovers | |
| SVHC list under REACH now 29-strong
14 more added to previous 15 by EChA | |
| Chemtura to sell PVC additives
SK Capital agrees deal, subject to court approval | |
| Marksans to divest API plants
Change of strategy for Indian pharma-CRAMS firm | |
| Production begins at Ningbo
AkzoNobel starts chelates facility | |
| Three into one
Univar Specialty Consumables unites three businesses | |
| Tronox aborts Huntsman agreement
Bondholders take bankrupt firm to restructuring | |
| Industry raises white flag over decaBDE
Flame retardant to be phased out in US by 2013 | |
| German fund to buy Isochem?
SNPE in exclusive negotiations, says French press | |
| Two UK biologics facilities change hands
Avecia Biologics to Merck, Cobra to Recipharm 21 December 2009 | |
| A taste for expansion
Sensient opens Chinese, Costa Rica facilities | |
| Ashland exits wood rosin and terpenes
Former Hercules site sold in continuing core focus | |
| ICL completes six acquisitions
Water and hygiene the focus of spate of buys | |
| Kiri rides to DyStar’s rescue
All facilities bar one to be acquired 14 December 2009 | |
| Nalco opens Shanghai centre
Key functions for Asia-Pacific under one roof | |
| Chemtura, Huntsman looking to Saudi market
New venture moves on, facility mulled | |